Pediatric Immune System Ontogeny and Development (INTEND) (R01 Clinical Trial Not Allowed)
Key Information
Due Date: May 7, 2024
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Contact Info:
grantsinfo@nih.gov
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Overview
The grant specifically focuses on correlating immune system development patterns between distinct age groups such as newborns (neonates), infants, children and adolescents.
Additional areas of research associated with the INTEND grant involve exploring how the presence of infectious diseases, the body's microbiome, and varying environmental factors interact and affect the development of a pediatric immune system. Special emphasis is placed on examining the effects during pivotal developmental moments including during pregnancy and the post-natal period.
This funding opportunity does not allow clinical trials, according to the relevant grant moniker, R01.
Key Dates
Open Date: July 9, 2021
Application Due Date: May 7, 2024
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses